Visualize Bacteria in Diabetic Foot Ulcers with the MolecuLight i:X™

85% of non-traumatic lower limb amputations are preceded by a foot ulcer.1 Many of these amputations are preventable through regular foot exams, detection and management of infection, and regular debridement.2 Real-time visualization of potentially harmful bacteria with the MolecuLight i:X can help clinicians detect and manage bacterial load through guided debridement, guided cleaning, and appropriate use of antimicrobial dressings.

Image taken prior to cleaning and debridement in Standard Imaging ModeTM
Image taken prior to cleaning and debridement in Fluorescence Imaging ModeTM (presence of bacteria indicated by red color)

Patient Testimonial: “I check my feet every night. I have since I was a little girl. I have my husband double check my feet. I woke up and the wound was there. It wasn’t there when I went to bed. It seemed to be responding to treatment but all of a sudden things changed. It was getting bigger and then it started getting black. And I thought ‘this is going to be it, I’m going to lose the foot.’

Having a device that can see where the bacteria is, it gives me peace of mind knowing I can see it and the images help me better understand. It’s been an important part of my wound care, absolutely.”

Wound Etiology
  • Diabetic foot ulcer (open for 7 months)
Anatomical Location
  • Left heel
Patient Demographics
  • Female, 54 years old
Patient-Specific Challenges
  • Diabetic (> 40 years)
Patient’s General Care Paradigm
  • Antibacterial ointment and dressings
  • Collagenase cream
  • Hyperbaric oxygen therapy
Clinician Stated Utility of the MolecuLight i:X
  • Guided debridement and cleaning
  • Avoid the need for swabs
Images provided by Rose Raizman RN-EC, MSc, Rouge Valley Health System, ON, Canada
MolecuLight Clinical Case 0039.

1. Singh N et al, Preventing Foot Ulcers in Patients With Diabetes JAMA, 2005; 293(2):217-228.
2. Canadian Diabetes Association 2013 Clinical Practice Guidelines.